Inborn errors of IL-6 family cytokine responses
Tóm tắt
Từ khóa
Tài liệu tham khảo
Notarangelo, 2020, Human inborn errors of immunity: an expanding universe, Sci Immunol, 5, 10.1126/sciimmunol.abb1662
Murakami, 2019, Pleiotropy and specificity: insights from the interleukin 6 family of cytokines, Immunity, 50, 812, 10.1016/j.immuni.2019.03.027
Rose-John, 2018, Interleukin-6 family cytokines, Cold Spring Harb Perspect Biol, 10, 10.1101/cshperspect.a028415
Hunter, 2012, Interleukin-27: balancing protective and pathological immunity, Immunity, 37, 960, 10.1016/j.immuni.2012.11.003
Spencer, 2019, Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses, J Exp Med, 216, 1986, 10.1084/jem.20190344
Nahum, 2020, Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency, J Allergy Clin Immunol, 145, 1011, 10.1016/j.jaci.2019.11.015
Brischoux-Boucher, 2018, IL11RA-related crouzon-like autosomal recessive craniosynostosis in 10 new patients: resemblances and differences, Clin Genet, 94, 373, 10.1111/cge.13409
Ware, 1995, Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death, Development, 121, 1283, 10.1242/dev.121.5.1283
Dagoneau, 2004, Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome, Am J Hum Genet, 74, 298, 10.1086/381715
Kosfeld, 2017, Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations, Hum Mol Genet, 26, 1716, 10.1093/hmg/ddx086
Rousseau, 2006, Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient, Proc Natl Acad Sci U S A, 103, 10068, 10.1073/pnas.0509598103
Arita, 2008, Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis, Am J Hum Genet, 82, 73, 10.1016/j.ajhg.2007.09.002
Bagci, 2018, IL-31: a new key player in dermatology and beyond, J Allergy Clin Immunol, 141, 858, 10.1016/j.jaci.2017.10.045
Villarino, 2003, The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection, Immunity, 19, 645, 10.1016/S1074-7613(03)00300-5
Wang, 2014, Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Nat Med, 20, 633, 10.1038/nm.3554
Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306
Wang, 2016, A novel IL-23p/Ebi3 (IL-39) cytokine mediates inflammation in lupus-like mice, Eur J Immunol, 46, 1343, 10.1002/eji.201546095
Davis, 1966, Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses, Lancet, 1, 1013, 10.1016/S0140-6736(66)90119-X
Buckley, 1972, Extreme hyperimmunoglobulinemia E and undue susceptibility to infection, Pediatrics, 49, 59, 10.1542/peds.49.1.59
Grimbacher, 1999, Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder, N Engl J Med, 340, 692, 10.1056/NEJM199903043400904
Siegel, 2011, A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory, Immunity, 35, 806, 10.1016/j.immuni.2011.09.016
Minegishi, 2007, Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome, Nature, 448, 1058, 10.1038/nature06096
Holland, 2007, STAT3 mutations in the hyper-IgE syndrome, N Engl J Med, 357, 1608, 10.1056/NEJMoa073687
Natarajan, 2018, Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency, J Allergy Clin Immunol, 142, 993, 10.1016/j.jaci.2018.05.009
Khourieh, 2019, A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance, Proc Natl Acad Sci U S A, 116, 16463, 10.1073/pnas.1901409116
Glocker, 2009, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N Engl J Med, 361, 2033, 10.1056/NEJMoa0907206
Saito, 2011, Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells, J Exp Med, 208, 235, 10.1084/jem.20100799
Chen, 2020, Absence of GP130 cytokine receptor signaling causes extended Stuve-Wiedemann syndrome, J Exp Med, 217, 10.1084/jem.20191306
Schwerd, 2017, A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis, J Exp Med, 214, 2547, 10.1084/jem.20161810
Shahin, 2019, Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function, Haematologica, 104, 609, 10.3324/haematol.2018.194233
Chen, 2021, Functional and structural analysis of cytokine selective IL6ST defects that cause recessive hyper-IgE syndrome, J Allergy Clin Immunol, 10.1016/j.jaci.2021.02.044
Beziat, 2020, Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome, J Exp Med, 217
Milner, 2008, Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, Nature, 452, 773, 10.1038/nature06764
Annunziato, 2012, Defining the human T helper 17 cell phenotype, Trends Immunol, 33, 505, 10.1016/j.it.2012.05.004
Schwerd, 2020, A variant in IL6ST with a selective IL-11 signaling defect in human and mouse, Bone Res, 8, 24, 10.1038/s41413-020-0098-z
Beziat, 2018, A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity, Sci Immunol, 3, 10.1126/sciimmunol.aat4956
Frey-Jakobs, 2018, ZNF341 controls STAT3 expression and thereby immunocompetence, Sci Immunol, 3, 10.1126/sciimmunol.aat4941
Ben-Khemis, 2017, A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients, Mol Immunol, 90, 57, 10.1016/j.molimm.2017.06.248
Sassi, 2014, Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, J Allergy Clin Immunol, 133, 1410, 10.1016/j.jaci.2014.02.025
Zhang, 2014, Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment, J Allergy Clin Immunol, 133, 1400, 10.1016/j.jaci.2014.02.013
Ben-Ali, 2019, Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients, J Allergy Clin Immunol, 143, 1638, 10.1016/j.jaci.2018.12.987
Lyons, 2017, Correction: ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans, J Exp Med, 214, 1201, 10.1084/jem.2016143503082017c
Felgentreff, 2014, Severe eczema and hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders, Clin Immunol, 150, 43, 10.1016/j.clim.2013.11.008
Engelhardt, 2015, The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency, J Allergy Clin Immunol, 136, 402, 10.1016/j.jaci.2014.12.1945
Bousfiha, 2020, Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification, J Clin Immunol, 40, 66, 10.1007/s10875-020-00758-x
Minegishi, 2006, Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity, Immunity, 25, 745, 10.1016/j.immuni.2006.09.009
Milner, 2015, Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations, Blood, 125, 591, 10.1182/blood-2014-09-602763
Fabre, 2019, Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review, J Allergy Clin Immunol Pract, 7, 1958, 10.1016/j.jaip.2019.02.018
Gonzalez-Mancera, 2020, STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection, Respir Med Case Rep, 30
Materna-Kiryluk, 2021, Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy, Hum Mol Genet, 30, 226, 10.1093/hmg/ddab035
Ferreira, 2013, Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases, PLoS Genet, 9, 10.1371/journal.pgen.1003444
Esparza-Gordillo, 2013, A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis, J Allergy Clin Immunol, 132, 371, 10.1016/j.jaci.2013.01.057
Rosa, 2019, A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity, NPJ Genom Med, 4, 23, 10.1038/s41525-019-0097-4
Kousik Kundu, 2020, Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for twelve immune-mediated diseases, bioRxiv
Choy, 2020, Translating IL-6 biology into effective treatments, Nat Rev Rheumatol, 16, 335, 10.1038/s41584-020-0419-z
Danese, 2019, Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II), Gut, 68, 40, 10.1136/gutjnl-2017-314562
Schreiber, 2021, Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease, Gastroenterology, 10.1053/j.gastro.2021.02.062
RECOVERY Collaborative Group, 2021, Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 397, 1637, 10.1016/S0140-6736(21)00676-0
Salama, 2021, Tocilizumab in patients hospitalized with Covid-19 pneumonia, N Engl J Med, 384, 20, 10.1056/NEJMoa2030340
Rosas, 2021, Tocilizumab in hospitalized patients with severe Covid-19 pneumonia, N Engl J Med, 384, 1503, 10.1056/NEJMoa2028700
Stone, 2020, Efficacy of tocilizumab in patients hospitalized with Covid-19, N Engl J Med, 383, 2333, 10.1056/NEJMoa2028836
Metcalfe, 2020, Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: focus on interleukin 11, Front Immunol, 11, 1424, 10.3389/fimmu.2020.01424
West, 2017, Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease, Nat Med, 23, 579, 10.1038/nm.4307
Puel, 2008, Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6, J Immunol, 180, 647, 10.4049/jimmunol.180.1.647
Bloomfield, 2019, Anti-IL6 autoantibodies in an infant with CRP-less septic shock, Front Immunol, 10, 2629, 10.3389/fimmu.2019.02629
Pawar, 2019, Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study, Ann Rheum Dis, 78, 456, 10.1136/annrheumdis-2018-214367
Bhattacharya, 2020, Spontaneous gastrointestinal perforations in STAT3-deficient hyper-IgE syndrome, J Clin Immunol, 40, 1199, 10.1007/s10875-020-00836-0
Reid, 2018, In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody, Br J Clin Pharmacol, 84, 2280, 10.1111/bcp.13669
Mallalieu, 2019, Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial, Pediatr Rheumatol Online J, 17, 57, 10.1186/s12969-019-0364-z
Chandesris, 2012, Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey, Medicine (Baltimore), 91, e1, 10.1097/MD.0b013e31825f95b9